Table 1.
Stocking frequencies of top five common sulphadoxine/sulphalene-pyrimethamine (SP) and amodiaquine (AQ) branded products across 856 retail outlets visited during the initial round of the retail audit survey in 2002. Data presented as proportion of audited retail outlets stocking a given product
| SP |
AQ |
||
|---|---|---|---|
| Brand | Stocking frequency* (%) |
Brand | Stocking frequency* (%) |
| Tablets | |||
| Falcidin | 159 (18·6) | Malaratab® | 735 (85·9) |
| Fansidar® | 81 (9·5) | Betaquine® | 115 (13·4) |
| Metakelfin® | 54 (6·3) | Alphaquine® | 37 (4·3) |
| Orodar® | 49 (5·7) | Emoquin® | 23 (2·7) |
| Malodar® | 16 (1·9) | Camoquin® | 17 (2·0) |
| Others | 115 (13·4) | Others | 42 (4·9) |
| Suspensions | |||
| Pyralfin® | 20 (2·3) | Amobin® | 30 (3·5) |
| Falcigo® | 14 (1·6) | Malaramed® | 24 (2·8) |
| Falcidin® | 13 (1·5) | Malaratab® | 17 (2·0) |
| Intadoxin® | 12 (1·4) | Falciquin® | 16 (1·9) |
| Medifan® | 11 (1·3) | Kamoc® | 13 (1·5) |
| Others | 41 (4·8) | Others | 34 (4·0) |
*
Proportion of audited outlets stocking a given product. Only 852 outlets were stocking antimalarial drugs in the initial round of the retail audit.